Not prominently characterized
Retatrutide is already being called the next generation of medical weight loss, more powerful than Ozempic, Wegovy, or Mounjaro, and patients are actively trying to get their hands on it
Whether these translate to meaningful clinical improvements at the low injectable doses used is unclear
Because distinguishing new medication effects from MS symptoms can be difficult, start with a lower dose and maintain close communication with your neurologist and primary care physician
Mehwish, MBBS (Registrar, Internal Medicine), a valued member of WritersFramework Collective, has authored: Managing Blood Glucose During Ramadan: Expert Guidance for Patients with Type 2 Diabetes. The article delivers clear, evidence-based guidance on safe fasting, glucose monitoring, and risk assessment during Ramadan, aligned with internationally recognized recommendations including IDF-DAR and BIMA